Top section
Top section
◆ Predictions for Gulf issuance change shape again ◆ Investment grade firms to pick tricky path through autumn ◆ The Alphabet effect: hyperscalers hit Kangaroo market
Barclays is 21st in the CEEMEA bond league table so far in 2026
International investor participation in the region remains light
Data
More articles
More articles
More articles
-
The two largest equity index providers put A-shares in the spotlight this week, with FTSE Russell announcing it would begin including the stock in its emerging markets index from June 2019, and MSCI launching a consultation on granting A-shares a greater share of its EM indices. -
Metropolis Healthcare has filed a draft red herring prospectus for an IPO with the Indian markets regulator, more than two years after it first hired banks for the deal.
-
China Life Insurance Co is planning a return to the offshore bond market for capital after a drop in its core solvency ratio, while Industrial and Commercial Bank of China is seeking shareholders’ blessing for a Basel III additional tier one (AT1) deal.
-
Canara Bank has waived through a plan to raise new equity to the tune of Rp60bn ($830m) from a qualified institutional placement.
-
Shanghai Fosun Pharmaceutical Group is looking to spin off its biotechnology unit through a Hong Kong IPO.
-
In this third part of the GlobalRMB awards, we present our reasons for choosing the best issuers in the FIG, corporate and SSA categories — and praise the strong performance of one well-known foreign law firm.
Sub-sections
-
Sponsored by CAF – Development Bank of Latin America and the Caribbean
CAF gearing up to transform regional development
-
Sponsored by Emirates NBD Capital
Emirates NBD Capital: An unrivalled conduit for Middle East liquidity
-
-
Sponsored by European Investment Bank
European Investment Bank: Supporting sustainable development in North Africa
